Christine Erikstrup Hallgreen

2020

Differences and similarities in medicine use, perceptions and sharing among adolescents in two different educational settings

Vestergaard, S. K., Hallgreen, C. E., Ravn, P. & Kaae, S., 1 apr. 2020, I: International Journal of Adolescent Medicine and Health. DOI: https://doi.org/10.1515/ijamh-2017-0097, 9 s., 0097.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

2019

How and Why to Involve Patients in Drug Development: Perspectives from the Pharmaceutical Industry, Regulatory Authorities and Patient Organizations

Hansen, M. B., Nørgaard, L. S. & Hallgreen, C. E., 8 aug. 2019, I: Therapeutic Innovation & Regulatory Science. s. 1-9 9 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

3 Citationer (Scopus)

Impact of European Benefit-Risk reassessment procedures on drug prescribing practices in Denmark

De Bruin, M. L., Hallgreen, C. E. & Andersen, M., aug. 2019.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

The effectiveness of direct to healthcare professional communication – A systematic review of communication factor studies

Møllebæk, M., Kaae, S., De Bruin, M. L., Callréus, T., Jossan, S. & Hallgreen, C. E., maj 2019, I: Research in Social and Administrative Pharmacy. 15, 5, s. 475-482

Publikation: Bidrag til tidsskrift › Review › peer review

4 Citationer (Scopus)

2018

Impact of the 2012 pharmacovigilance legislation on the harmonisation of DHPCS in the EU

Olafsdottir, G., Bukhave, S. M., Kalligeros, G., Hallgreen, C. E. & De Bruin, M. L., aug. 2018, s. 515-516.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

2017

How to Measure the Impact of Pharmacovigilance Activities on Public Health?

Gardarsdottir, H., Kant, A., De Bruin, M. L., Hallgreen, C. E., Dal Pan, G. & Way, D., aug. 2017, s. 31-31.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

2016

Literature review of visual representation of the results of benefit-risk assessments of medicinal products

Hallgreen, C. E., Mt-Isa, S., Lieftucht, A., Phillips, L. D., Hughes, D., Talbot, S., Asiimwe, A., Downey, G., Genov, G., Hermann, R., Noel, R., Peters, R., Micaleff, A., Tzoulaki, I., Ashby, D. & PROTECT Benefit-Risk group, 1 mar. 2016, I: Pharmacoepidemiology and Drug Safety. 25, 3, s. 238-50 13 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

15 Citationer (Scopus)

Recommendations for benefit-risk assessment methodologies and visual representations

Hughes, D., Waddingham, E., Mt-Isa, S., Goginsky, A., Chan, E., Downey, G. F., Hallgreen, C. E., Hockley, K. S., Juhaeri, J., Lieftucht, A., Metcalf, M. A., Noel, R. A., Phillips, L. D., Ashby, D., Micaleff, A. & PROTECT Benefit-Risk Group, 1 mar. 2016, I: Pharmacoepidemiology and Drug Safety. 25, 3, s. 251-62 12 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

32 Citationer (Scopus)

Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance

Aagaard, L., Hallgreen, C. E. & Hansen, E. H., 1 nov. 2016, I: International journal of obesity (2005). 40, 11, s. 1742-1747 6 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

10 Citationer (Scopus)

2014

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

Mt-Isa, S., Hallgreen, C. E., Wang, N., Callréus, T., Genov, G., Hirsch, I., Hobbiger, S. F., Hockley, K. S., Luciani, D., Phillips, L. D., Quartey, G., Sarac, S. B., Stoeckert, I., Tzoulaki, I., Micaleff, A., Ashby, D. & IMI-PROTECT benefit-risk participants, 1 jul. 2014, I: Pharmacoepidemiology and Drug Safety. 23, 7, s. 667-78 12 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

68 Citationer (Scopus)

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

Hallgreen, C. E., van den Ham, H. A., Mt-Isa, S., Ashworth, S., Hermann, R., Hobbiger, S., Luciani, D., Micaleff, A., Thomson, A., Wang, N., van Staa, T. P., Downey, G., Hirsch, I., Hockley, K., Juhaeri, J., Metcalf, M., Mwangi, J., Nixon, R., Peters, R., Stoeckert, I., & 4 flereWaddingham, E., Tzoulaki, I., Ashby, D. & Wise, L., sep. 2014, I: Pharmacoepidemiology and Drug Safety. 23, 9, s. 974-983 10 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

16 Citationer (Scopus)

2009

A model of NEFA dynamics with focus on the postprandial state

Jelic, K., Hallgreen, C. E. & Colding-Jørgensen, M., sep. 2009, I: Annals of Biomedical Engineering. 37, 9, s. 1897-1909 13 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

24 Citationer (Scopus)

2008

Allometric relationship between changes of visceral fat and total fat mass

Hallgreen, C. E. & Hall, K. D., maj 2008, I: International Journal of Obesity. 32, 5, s. 845-852 8 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

37 Citationer (Scopus)

Increasing weight loss attenuates the preferential loss of visceral compared with subcutaneous fat: A predicted result of an allometric model

Hall, K. D. & Hallgreen, C. E., apr. 2008, I: International Journal of Obesity. 32, 4, s. 722 1 s.

Publikation: Bidrag til tidsskrift › Letter › peer review

23 Citationer (Scopus)

The Glucose-Insulin Control System

Hallgreen, C. E., Korsgaard, T. V., Hansen, R. N. & Colding-Jørgensen, M., 11 jul. 2008, Biosimulation in Drug Development. Wiley-VCH, s. 141-196 56 s.

Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › peer review

4 Citationer (Scopus)

Christine Erikstrup Hallgreen

Publikation

Søgeresultater